Jeffrey Rubnitz
Overview
Explore the profile of Jeffrey Rubnitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
729
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang L, Voss R, Pastor V, Cardenas M, Kumar P, Maciaszek J, et al.
Res Sq
. 2025 Feb;
PMID: 39975890
Pediatric acute myeloid leukemia (AML) exhibits distinct genetic characteristics, including unique driver alterations and mutations with prognostic and therapeutic significance. Emerging rare, recurrent genetic abnormalities and their associations with outcomes...
2.
Umeda M, Hiltenbrand R, Michmerhuizen N, Barajas J, Thomas M, Arthur B, et al.
medRxiv
. 2025 Feb;
PMID: 39974131
Leukemias with rearrangements exhibit heterogeneous phenotypes correlated to fusion partners, whereas the mechanism responsible for this heterogeneity is poorly understood. Through genome-wide mutational and transcriptional analyses of 177 -rearranged leukemias,...
3.
Nguyen N, Nguyen N, Rafiee R, Parcha P, Parcha P, Tagmount A, et al.
Blood Adv
. 2024 Dec;
9(5):1078-1091.
PMID: 39715471
Cytarabine, daunorubicin, and etoposide (ADE) have been the standard backbone of induction chemotherapy regimen for patients with pediatric acute myeloid leukemia (pAML) for >5 decades. However, chemoresistance is still a...
4.
Lamba J, Marchi F, Landwehr M, Schade A, Shastri V, Ghavami M, et al.
Res Sq
. 2024 Dec;
PMID: 39711573
Acute Myeloid Leukemia (AML) is an aggressive cancer with dismal outcomes, vast subtype heterogeneity, and suboptimal risk stratification. In this study, we harmonized DNA methylation data from 3,314 patients across...
5.
H Elsayed A, Cao X, Marrero R, Nguyen N, Wu H, Ni Y, et al.
NPJ Precis Oncol
. 2024 Aug;
8(1):168.
PMID: 39090192
In this study, we leveraged machine-learning tools by evaluating expression of genes of pharmacological relevance to standard-AML chemotherapy (ara-C/daunorubicin/etoposide) in a discovery-cohort of pediatric AML patients (N = 163; NCT00136084...
6.
Newman H, Li Y, Huang Y, Elgarten C, Myers R, Ruiz J, et al.
Cancer Med
. 2024 Apr;
13(7):e6966.
PMID: 38572962
Objective: Examine the influence of household income on health-related quality of life (HRQOL) among children with newly diagnosed acute myeloid leukemia (AML). Design: Secondary analysis of data prospectively collected from...
7.
Goggin K, Lu L, Lee D, Howell C, Srivastava D, Brinkman T, et al.
JAMA Netw Open
. 2024 Mar;
7(3):e242727.
PMID: 38497960
Importance: Children undergoing treatment for leukemia are at increased risk of severe sepsis, a dysregulated immune response to infection leading to acute organ dysfunction. As cancer survivors, they face a...
8.
Gandy K, Hall L, Krull K, Esbensen A, Rubnitz J, Jacola L
Cancer Med
. 2024 Jan;
13(3):e6842.
PMID: 38240104
Objective: The primary aim of this study was to assess the feasibility of a developmentally tailored neurocognitive assessment in survivors of childhood acute leukemia with Down syndrome (DS-leukemia). A secondary...
9.
Huang B, Smith J, Farrar J, Wang Y, Umeda M, Ries R, et al.
Nat Commun
. 2022 Sep;
13(1):5487.
PMID: 36123353
Relapsed or refractory pediatric acute myeloid leukemia (AML) is associated with poor outcomes and relapse risk prediction approaches have not changed significantly in decades. To build a robust transcriptional risk...
10.
Bami S, Hidinger J, Madni A, Hargest V, Schultz-Cherry S, Cortez V, et al.
J Pediatric Infect Dis Soc
. 2022 Jul;
11(9):408-412.
PMID: 35849135
Novel human astroviruses (HAstVs) have recently been implicated as rare causes of fatal encephalitis in immunocompromised patients, for which there is no proven treatment. We report 2 cases from our...